Hormones with statins may help women's hearts after menopause

March 17, 2015

CLEVELAND, Ohio (March 17, 2015)--Hormones may not protect women from heart disease or stroke after menopause, but when combined with cholesterol-lowering statin drugs, they may help protect women from these killers, shows a population study from Sweden to be published in the April issue of Menopause, the journal of The North American Menopause Society (NAMS). During the study, women who took both hormones and statins had a significantly lower risk of dying of any cause and a moderately lower risk of dying of cardiovascular disease.

Using health information from national Swedish health registers on some 40,000 women who took statins, this study compared the records of deaths and cardiovascular events, such as heart attack and stroke, between some 3,000 women who also used hormone therapy and some 38,000 who did not. They were followed up for a mean of four years. Most of the women (70%) were using statins for primary prevention of heart disease, that is, they had not had a cardiovascular event such as heart attack or stroke. The others had had an event so were taking statins for secondary prevention.

The rate of death from any cause was 33/10,000 person-years for women who used hormone therapy with statins compared with 87/10,000 person years for women who used statins alone--a significant difference. Although the rates of cardiovascular events, such as heart attack or stroke, were no different between the groups, the rates of death from cardiovascular disease were lower in the women who used both therapies (5/10,000 person years) than in the women who used statins alone (18/10,000 person years), but this difference was not as definite statistically. These differences were consistent whether the women took statins for primary or for secondary prevention.

The potential beneficial effect on cardiovascular deaths contrasts with the results of the Women's Health Initiative (WHI) and the Heart and Estrogen/progestin Replacement Study (HERS). The reason, the researchers speculated, might be that women in the WHI and HERS took conjugated estrogens, which aren't available in Sweden, whereas the Swedish women used 17-beta estradiol, the estrogen that women most commonly make before menopause. The authors pointed out that a European study with hormone therapy using 17-beta estradiol showed some reduced, not increased, risk of death and heart attack.

Another reason, they said, is that statins may lessen the risk of coronary heart events that tend to occur early on in hormone therapy. That is because estrogen may make plaque in the arteries unstable, leading to blood clots and heart attacks and strokes.

As an accompanying editorial pointed out, in the HERS study, heart attacks did increase soon after women began taking hormones, but there was a significant decrease in heart disease after that. Combining hormone therapy with statins might be an advantage not only by preventing early heart attacks and offering cardiovascular benefits later but also by avoiding the onset of type-2 diabetes that statins may cause. These are questions that a properly conducted, randomized trial could answer, the editorial said.

"This report provides intriguing information on the benefits of simultaneous use of statins and hormone therapy in women considered to be at risk for cardiovascular disease. Its findings suggest that one benefit of each treatment offsets one adverse effect of the other treatment, thereby yielding better health outcomes in combination than what could be achieved by either medication alone," says NAMS Executive Director Margery Gass, MD. "These results call for further study of the combined use of hormone therapy and statins."
-end-
Founded in 1989, The North American Menopause Society (NAMS) is North America's leading nonprofit organization dedicated to promoting the health and quality of life of all women during midlife and beyond through an understanding of menopause and healthy aging. Its multidisciplinary membership of 2,000 leaders in the field--including clinical and basic science experts from medicine, nursing, sociology, psychology, nutrition, anthropology, epidemiology, pharmacy, and education--makes NAMS uniquely qualified to serve as the definitive resource for health professionals and the public for accurate, unbiased information about menopause and healthy aging. To learn more about NAMS, visit http://www.menopause.org.

The North American Menopause Society (NAMS)

Related Heart Disease Articles from Brightsurf:

Cellular pathway of genetic heart disease similar to neurodegenerative disease
Research on a genetic heart disease has uncovered a new and unexpected mechanism for heart failure.

Mechanism linking gum disease to heart disease, other inflammatory conditions discovered
The link between periodontal (gum) disease and other inflammatory conditions such as heart disease and diabetes has long been established, but the mechanism behind that association has, until now, remained a mystery.

New 'atlas' of human heart cells first step toward precision treatments for heart disease
Scientists have for the first time documented all of the different cell types and genes expressed in the healthy human heart, in research published in the journal Nature.

With a heavy heart: How men and women develop heart disease differently
A new study by researchers from McGill University has uncovered that minerals causing aortic heart valve blockage in men and women are different, a discovery that could change how heart disease is diagnosed and treated.

Heart-healthy diets are naturally low in dietary cholesterol and can help to reduce the risk of heart disease and stroke
Eating a heart-healthy dietary pattern rich in vegetables, fruits, whole grains, low-fat dairy products, poultry, fish, legumes, vegetable oils and nuts, which is also limits salt, red and processed meats, refined-carbohydrates and added sugars, is relatively low in dietary cholesterol and supports healthy levels of artery-clogging LDL cholesterol.

Pacemakers can improve heart function in patients with chemotherapy-induced heart disease
Research has shown that treating chemotherapy-induced cardiomyopathy with commercially available cardiac resynchronization therapy (CRT) delivered through a surgically implanted defibrillator or pacemaker can significantly improve patient outcomes.

Arsenic in drinking water may change heart structure raising risk of heart disease
Drinking water that is contaminated with arsenic may lead to thickening of the heart's main pumping chamber in young adults, according to a new study by researchers at Columbia University Mailman School of Public Health.

New health calculator can help predict heart disease risk, estimate heart age
A new online health calculator can help people determine their risk of heart disease, as well as their heart age, accounting for sociodemographic factors such as ethnicity, sense of belonging and education, as well as health status and lifestyle behaviors.

Wide variation in rate of death between VA hospitals for patients with heart disease, heart failure
Death rates for veterans with ischemic heart disease and chronic heart failure varied widely across the Veterans Affairs (VA) health care system from 2010 to 2014, which could suggest differences in the quality of cardiovascular health care provided by VA medical centers.

Heart failure: The Alzheimer's disease of the heart?
Similar to how protein clumps build up in the brain in people with some neurodegenerative diseases such as Alzheimer's and Parkinson's diseases, protein clumps appear to accumulate in the diseased hearts of mice and people with heart failure, according to a team led by Johns Hopkins University researchers.

Read More: Heart Disease News and Heart Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.